Pharmaceutical Investment Is Entering a New Phase — CMI to Share Market Intelligence at Pharmaconex 2026
Pharmaceutical investment decisions are becoming increasingly complex. Companies looking to expand manufacturing capacity are assessing more than market demand alone, with supply chain resilience, regional production, regulatory requirements, operating costs, and geopolitical considerations all influencing where new capital is directed. Against this changing backdrop, Coherent Market Insights...
0 التعليقات 0 المشاركات 336 مشاهدة 0 معاينة
Urh Social https://urh.app